Corvus Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -29 | -26 | ||
EBITDA | -17,187 | -11,879 | -12,295 | -10,129 |
EBIT | -17,250 | -11,908 | -12,321 | -10,157 |
Net Income | -17,959 | -13,692 | -12,321 | -10,157 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -15,980 | -10,465 | -9,216 | -9,566 |
Cash | 18,905 | 40,102 | 4,576 | 2,867 |
Basic Shares | 92,368 | 89,996 | 79,742 | 82,836 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -105 | -85 | -151 | -367 |
EBITDA | -15,178 | -62,208 | -26,878 | -40,940 |
EBIT | -15,283 | -62,293 | -27,029 | -41,307 |
Net Income | -15,283 | -62,293 | -27,029 | -41,307 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -32,971 | -25,424 | -23,969 | -27,292 |
Cash | 4,576 | 8,740 | 12,620 | 13,159 |
Basic Shares | 79,742 | 60,985 | 48,025 | 46,553 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.19 |
2026-03-31 | -$0.15 |
2025-12-31 | -$0.15 |
2025-09-30 | -$0.12 |